88 related articles for article (PubMed ID: 6330650)
1. [Resistance of Enterobacteria to cefotaxime and lamoxactam at the Pitié-Salpêtrière Hospital in 1982].
Nicolas MH; Jarlier V; Fievet MH; Nguyen J; Truffot C
Pathol Biol (Paris); 1984 May; 32(5):393-5. PubMed ID: 6330650
[TBL] [Abstract][Full Text] [Related]
2. [Enterobacter cloacae. In vivo emergence of a variant resistant to new beta-lactams during treatment with lamoxactam-gentamicin].
Jarlier V; Philippon A; Nicolas MH; Bismuth R; Paul G; Fusciardi J
Pathol Biol (Paris); 1984 May; 32(5):399-403. PubMed ID: 6739148
[TBL] [Abstract][Full Text] [Related]
3. [Cefotaxime, moxalactam and ceftriaxone: comparison of in vitro activity against hospital strains of Enterobacteriaceae belonging to the 4 principal phenotypes of sensitivity to beta-lactams].
Jarlier V; Bismuth R; Grosset J
Pathol Biol (Paris); 1983 May; 31(5):336-42. PubMed ID: 6312393
[TBL] [Abstract][Full Text] [Related]
4. [In vitro activity of combinations of cefotaxime and moxalactam with aminoglycosides on beta-lactamase-producing Enterobacteriaceae].
Sirot J; Sirot D; Garnier R; Joly B; Cluzel R
Pathol Biol (Paris); 1983 Jun; 31(6):480-2. PubMed ID: 6308542
[TBL] [Abstract][Full Text] [Related]
5. [In vitro activity of cefotaxime, latamoxef and ceftriaxone on hospital strains of Enterobacteriaceae resistant to cefalotine and cefoxitine].
Berche P; Gaillard JL
Ann Biol Clin (Paris); 1986; 44(6):624-7. PubMed ID: 3826779
[TBL] [Abstract][Full Text] [Related]
6. Survey of the phenotypes of susceptibility to beta-lactams in Enterobacteriaceae at the Pitie-Salpetriere Hospital.
Jarlier V; Bismuth R; Nicolas MH; Nguyen J; Truffot C; Grosset J
J Antimicrob Chemother; 1984 Sep; 14 Suppl B():59-65. PubMed ID: 6501135
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of temocillin, moxalactam and cefotaxime against gram negative bacteria sensitive or resistant to ureidopenicillins and/or cefacedone.
Bartmann K; Tarbuc R
Zentralbl Bakteriol Mikrobiol Hyg A; 1983 Dec; 256(2):202-10. PubMed ID: 6324518
[TBL] [Abstract][Full Text] [Related]
8. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.
Lewis JS; Herrera M; Wickes B; Patterson JE; Jorgensen JH
Antimicrob Agents Chemother; 2007 Nov; 51(11):4015-21. PubMed ID: 17724160
[TBL] [Abstract][Full Text] [Related]
9. [Development of Beta-lactamase resistance in enterobacteria].
Koren J; Vaculíková A
Klin Mikrobiol Infekc Lek; 2006 Jun; 12(3):103-7. PubMed ID: 17051471
[TBL] [Abstract][Full Text] [Related]
10. Population analysis of susceptibility to cefotaxime in Enterobacteriaceae.
Søgaard P
Acta Pathol Microbiol Immunol Scand B; 1985 Oct; 93(5):365-9. PubMed ID: 4083013
[TBL] [Abstract][Full Text] [Related]
11. [Sensitivity to fosfomycin of bacteria isolated at the Pitié-Salpétrière Hospital in 1982 and 1983].
Bismuth R; Jarlier V; Nicolas MH; Nguyen J; Truffot C
Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):520-4. PubMed ID: 6431379
[TBL] [Abstract][Full Text] [Related]
12. [In vitro activity of cefatiolene (RP 42,980) against hospital bacteria. Comparison with cefotaxime and lamoxactam. Results of a multicenter study].
Duval J; Soussy CJ; Deforges L; Le Van Thoi J; Acar JF; Kitzis D; Dabernat H; Christol D; Bure A; Courtieu AL
Pathol Biol (Paris); 1983 May; 31(5):357-61. PubMed ID: 6312397
[TBL] [Abstract][Full Text] [Related]
13. [In vitro evaluation of moxalactam on enterobacteria producing beta-lactamases].
Kazmierczak A; Pechinot A; Duez JM; Kohli E; Tremeaux JC
Sem Hop; 1983 Jun; 59(26):1953-7. PubMed ID: 6310785
[TBL] [Abstract][Full Text] [Related]
14. Spread of novel expanded-spectrum beta-lactamases in Enterobacteriaceae in a university hospital in the Paris area, France.
Lartigue MF; Fortineau N; Nordmann P
Clin Microbiol Infect; 2005 Jul; 11(7):588-91. PubMed ID: 15966981
[TBL] [Abstract][Full Text] [Related]
15. [Susceptibility of clinical isolates to cefotaxime. Comparison to new antibiotics latamoxef, cefoperazone, and ceftizoxime].
Asari S; Horikawa M; Tsukamoto H; Shimizu Y; Koda K; Hayashi C; Miyai K
Jpn J Antibiot; 1984 Feb; 37(2):267-78. PubMed ID: 6330393
[TBL] [Abstract][Full Text] [Related]
16. Epidemiological study of Enterobacter cloacae resistant to 3rd generation cephalosporins: a preliminary report.
Giamarellou H; Koratzanis G; Kanellakopoulou K; Daikos GK
Chemioterapia; 1985 Feb; 4(1):43-6. PubMed ID: 3986944
[TBL] [Abstract][Full Text] [Related]
17. Activity of cefotaxime and amikacin against 14,272 gram-negative bacteria from clinical samples in the period 1980 to 1985.
Dámaso D; Sánchez-Moreno MP; Martínez-Martínez L; Mesa E; Portero F; Mendaza P; Daza RM
Drugs; 1988; 35 Suppl 2():1-5. PubMed ID: 3396470
[TBL] [Abstract][Full Text] [Related]
18. [Enterobacteriaceae isolated in nine general hospitals of the Ile-de-France in 1988 and 1989: susceptibility to beta-lactam antibiotics according to the length of hospitalisation].
Pean Y; Hacquard B; Berardi-Grassias L; Boisivon A; Bejot J; Eme A; Le Pennec MP; Morice J; Rouchon M; Gertner J
Pathol Biol (Paris); 1991 May; 39(5):486-8. PubMed ID: 1881679
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of CHROMagar CTX, a novel medium for isolating CTX-M-ESBL-positive Enterobacteriaceae while inhibiting AmpC-producing strains.
Randall LP; Kirchner M; Teale CJ; Coldham NG; Liebana E; Clifton-Hadley F
J Antimicrob Chemother; 2009 Feb; 63(2):302-8. PubMed ID: 19043079
[TBL] [Abstract][Full Text] [Related]
20. [Effect of multiresistance on the minimal inhibitory concentration of N-formimidoyl thienamycin and 6 comparing substances against P. aeruginosa and 4 Enterobacteriaceae species].
Schröter G; Schrettenbrunner A; Strenzel I
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Feb; 253(4):531-43. PubMed ID: 6407236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
